A single-chain antibody-CD39 fusion protein targeting activated platelets protects from cardiac ischaemia/reperfusion injury-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A single-chain antibody-CD39 fusion protein targeting activated platelets protects from cardiac ischaemia/reperfusion injury

Published:2017-05-02 Issue: Volume: Page:
ISSN:0195-668X
Container-title:European Heart Journal
language:en
Short-container-title:

Author:

Ziegler Melanie,Hohmann Jan David,Searle Amy Kate,Abraham Meike-Kristin,Nandurkar Harshal H.,Wang Xiaowei,Peter Karlheinz

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/eurheartj/article-pdf/doi/10.1093/eurheartj/ehx218/14097307/ehx218.pdf

Reference19 articles.

1. Cell biology of ischemia/reperfusion injury;Int Rev Cell Mol Biol,2012

2. CD39 and CD73 in immunity and inflammation;Trends Mol Med,2013

3. Ectonucleotidases of CD39 family modulate vascular inflammation and thrombosis in transplantation;Semin Thromb Hemost,2005

4. Delayed targeting of CD39 to activated platelet GPIIb/IIIa via a single-chain antibody: breaking the link between antithrombotic potency and bleeding?;Blood,2013

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fibroblasts and platelets: a face-to-face dialogue at the heart of cardiac fibrosis;American Journal of Physiology-Heart and Circulatory Physiology;2024-03-01

2. Dual‐modality imaging for identifying thrombosis via platelet GPIIb/IIIa receptor targeted cyclic RGDfK microbubbles;iRADIOLOGY;2024-02-16

3. Platelet-targeted thromboprophylaxis with a human serum albumin fusion drug: Preventing thrombosis and reducing cardiac ischemia/reperfusion injurywithout bleeding complications;Theranostics;2024

4. What do we know about platelets in myocardial ischemia-reperfusion injury and why is it important?;Thrombosis Research;2023-09

5. The relative importance of platelet integrins in hemostasis, thrombosis and beyond;Haematologica;2023-01-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3